Bright Minds Biosciences Inc stock is traded at $22.00, with a volume of 47,453. It is up +6.28% in the last 24 hours and down -54.40% over the past month. Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
Previous Close:
$20.70
Open:
$21.29
24h Volume:
47,453
Relative Volume:
0.11
Market Cap:
$217.01M
Revenue:
-
Net Income/Loss:
-$19.80M
P/E Ratio:
-
EPS:
-$2.44
Net Cash Flow:
-$14.56M
1W Performance:
-59.99%
1M Performance:
-54.40%
6M Performance:
-75.25%
1Y Performance:
-60.79%
1-Day Range:
$20.70$22.11
1-Week Range:
$17.40$29.94
52-Week Range:
$17.40$123.75
Bright Minds Biosciences Inc Stock (DRUG) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS